Antibiotic resistance: Why aren’t drug companies developing new medicines to stop superbugs?

Antibiotics are a critical class of drugs that have failed to earn much investment by pharmaceutical companies in recent years. The industry cites their lack of profitability, so the U.S. government is stepping in with incentives and quick regulatory approvals.